Dermatology Times, April 2022 (Vol. 43. No. 4)

“With a traditional QRP [qualified retirement plan], a participant trades today’s tax rates on their contribution for the tax rates in the future, when they withdraw the money from the plan. If rates rise, the QRP might prove not to be a good deal at all.”

“Microneedling has been touted to the consumer as a means to enhance the penetration of moisturizers, vitamins, skin-lightening ingredients, and other cosmeceuticals. Is this enhanced penetration good? It depends.”

Now, with an increasing emphasis on multidisciplinary tumor review boards and heightened expectations for pipeline drugs, physicians have new tools for building treatment plans that may push response rates beyond the 30% range.

In this month's Legal Eagle, David J. Goldberg, MD, JD, dives into a case of amount for fees charged for medical records.

Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.

Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.

Investigator Loren Krueger, MD, urges dermatologists to recognize and correct disparities in clinical decision-making, particularly regarding skin cancer.

A recent study aimed to identify whether using specific serum biomarkers could predict therapeutic response in patients with atopic dermatitis.

In a recent study from the Journal of the American Academy of Dermatology, investigators assessed symptoms, disease burden, and use of analgesics in patients with or without psoriatic arthritis.

A recent study examined the role of inflammation and psoriasis in cardiometabolic diseases, focusing on metabolic syndrome and its components.

A recent study examined the possibility of using an mRNA vaccine to prevent the development of skin cancer.

Specific genetic variations could be key in identifying acne risk far before the signs arise.

Dermatology Times® interviews editorial board member Richard Gallo, MD, PhD, who dives into what is currently lacking is rosacea patient care, how the new mechanisms of action of these potential treatments will better address current struggles, and more.

A study in the Journal of Clinical and Aesthetic Dermatology dove into the hereditary predisposition of rosacea within families.

The American Academy of Dermatology’s newest guideline focuses on awareness of other health conditions associated with atopic dermatitis in adult patients.

A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.

Sunscreen advice, recruiting during the “Great Recession”, and tips for the office led the busy agenda at Winter Clinical Dermatology Conference this weekend.